Mayank Mamtani

Stock Analyst at B. Riley Securities

(1.26)
# 1831
Out of 5,356 analysts
176
Total ratings
35.85%
Success rate
7.78%
Average return
46 Stocks
Name Action PT Current % Upside Ratings Updated
MGNX Macrogenics
Maintains: Neutral
5 3
1.44 108.33% 2 May 20, 2025
MDGL Madrigal Pharmaceuti...
Reiterates: Strong Buy
422 460
274.13 67.8% 12 May 2, 2025
HROW Harrow
Maintains: Buy
69 65
28.75 126.09% 2 Apr 1, 2025
VXRT Vaxart
Maintains: Buy
3 2
0.39 412.82% 6 Mar 27, 2025
TRVI Trevi Therapeutics
Reiterates: Strong Buy
11 20
6.77 195.42% 3 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 3
0.66 354.55% 2 Mar 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
38 35
14.21 146.31% 2 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
51 38
16.48 130.58% 7 Feb 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
109 96
27.02 255.29% 2 Feb 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
0.67 497.01% 1 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
1 2
0.29 417.24% 3 Dec 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
23 26
6.99 271.96% 19 Oct 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3 1
n/a n/a 4 Oct 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
33
11.9 177.31% 1 Sep 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
5.45 266.97% 9 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
29 34
39.25 -13.38% 13 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
122 92
32.07 186.87% 3 Jun 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
29 33
n/a n/a 7 Feb 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 4
4.26 -6.1% 3 Dec 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
7 4
n/a n/a 5 Nov 22, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
140
6.36 2101.26% 1 Oct 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
15 19
n/a n/a 11 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
210 90
3.75 2300% 5 Apr 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
160
5.13 3018.91% 1 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
2 1
n/a n/a 4 Nov 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
11 5
1.89 164.55% 3 Aug 19, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
58 44
2.12 1975.47% 4 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
120 90
1.89 4661.9% 4 Jul 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
14 7
7.38 -5.15% 3 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
600 450
n/a n/a 1 Mar 29, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
850 500
n/a n/a 1 Mar 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1
n/a n/a 6 Mar 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 8
n/a n/a 2 Mar 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
23040 15360
n/a n/a 2 Mar 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9750 4500
1.25 359900% 3 Jan 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
500 270
1.08 24900% 2 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
200
n/a n/a 1 May 27, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
138 77
11.9 547.06% 2 Jan 15, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
96
n/a n/a 2 Jul 6, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1980 1440
1.49 96544.3% 3 May 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 4
1.29 210.08% 2 Apr 3, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
70 30
n/a n/a 2 Apr 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
47 39
97.96 -60.19% 2 Mar 18, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
22 11
1.39 691.37% 1 Mar 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
43 34
4.29 692.54% 1 Mar 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
14 20
n/a n/a 1 Dec 10, 2019